Basic Stalevo Information

• INN (International Nonproprietary Name): Levodopa, Carbidopa, Entacapone.
• Brand Names Available In United States: not specified.
• ATC Code: N04BA03 (Levodopa combinations).
• Forms & Dosages: Film-coated tablets for oral use; all strengths contain 200 mg entacapone with varying levodopa/carbidopa:
  • Stalevo 50 — 50 mg levodopa + 12.5 mg carbidopa + 200 mg entacapone.
  • Stalevo 75 — 75 mg levodopa + 18.75 mg carbidopa + 200 mg entacapone.
  • Stalevo 100 — 100 mg levodopa + 25 mg carbidopa + 200 mg entacapone.
  • Stalevo 125 — 125 mg levodopa + 31.25 mg carbidopa + 200 mg entacapone.
  • Stalevo 150 — 150 mg levodopa + 37.5 mg carbidopa + 200 mg entacapone.
  • Stalevo 200 — 200 mg levodopa + 50 mg carbidopa + 200 mg entacapone.
• Manufacturers In United States: not specified.
• Registration Status In United States: FDA-approved since June 11, 2003 (NDA #021485).
• OTC / Rx Classification: Prescription only medicine (Rx); not available over the counter in major regulated markets.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Worried about unpredictable "on" and "off" times during the day?

Take Stalevo at consistent times each day to help keep motor symptoms stable.

Most people take one tablet per dose, typically three to seven times daily, matched to their prior levodopa/DDCI schedule.

Your neurologist will choose the closest Stalevo tablet strength to match your current levodopa dose and dosing frequency.

If you need fewer evening doses because of vivid dreams or insomnia, discuss spacing with your clinician rather than skipping doses.

Keep a simple dosing chart or use a labeled pill organizer to avoid missed or doubled doses.

• Daily Dosing Checklist:
  • Take Stalevo at the same times each day.
  • Confirm tablet strength matches your previous levodopa/carbidopa dose.
  • Track "on" and "off" times for your clinic visits.
  • Do not split combined tablets without prescriber approval.

Safety Priorities

Who Should Avoid It

Concerned whether Stalevo is safe for you?

Do not take Stalevo if you have known hypersensitivity to levodopa, carbidopa, or entacapone.

Also avoid Stalevo with narrow-angle glaucoma, severe liver disease, or pheochromocytoma.

Tell your prescriber about heart disease, psychosis, severe renal impairment, or any prior reactions to dopaminergic drugs.

Stalevo is not indicated for patients under 18 years of age.

• Contraindications Checklist:
  • Known allergy to any component (levodopa/carbidopa/entacapone).
  • Narrow-angle glaucoma.
  • Severe hepatic impairment.
  • Pheochromocytoma.

Activities To Limit

Worried about side effects while you work or drive?

Avoid driving or operating heavy machinery until you know how Stalevo affects you due to dizziness or sudden sleep episodes.

Rise slowly from sitting or lying down because orthostatic hypotension can occur.

Avoid combining Stalevo with non-selective MAO inhibitors.

Carry a medication card listing Stalevo (levodopa/carbidopa/entacapone) so medical teams can act quickly in an emergency.

Dosage & Adjustments

General Regimen

Need a simple plan to match your current medications?

Stalevo dosing is individualized by matching the tablet to your current levodopa/DDCI regimen.

Maintenance dosing is commonly one tablet per dose, three to seven times daily, adjusted for symptom control.

All marketed Stalevo tablets contain 200 mg entacapone with varying levodopa/carbidopa amounts; choose the tablet closest to your prior levodopa dose.

Do not exceed 200 mg levodopa per dose or 2,000 mg levodopa per day.

Special Cases

Wondering about older adults or organ impairment?

Elderly patients usually start at a lower dose and increase slowly based on tolerability.

Stalevo is not indicated for children under 18 years.

Use caution and monitor renal impairment carefully.

Avoid or reduce dose in significant hepatic impairment because entacapone exposure increases.

If you miss a dose, take it as soon as remembered but do not double the next dose.

1. Match current levodopa/DDCI dose to closest Stalevo tablet.
2. Start at equivalent frequency (3–7 times daily).
3. Monitor symptoms and side effects for clinic-guided titration.

User Testimonials

Positive Reports

Curious how other people felt after switching?

Many patients report smoother "on" periods and reduced wearing-off after switching to Stalevo compared with levodopa/DDCI alone.

Reports commonly describe improved walking, fewer sudden slowdowns, and a simpler pill routine thanks to the fixed entacapone per dose.

Common Challenges

What problems do people commonly see?

Users often mention increased dyskinesia, nausea, sleep disturbances, and urine discoloration as side effects to watch for.

Patients also note the practical need to time Stalevo around protein-heavy meals for best effect.

• Tips From Users:
  • Keep a symptom diary noting on/off times and dyskinesia.
  • Record exact dosing times and meals to discuss at clinic visits.
  • Bring tablet samples or photos to appointments to confirm strengths.

"Switched to Stalevo and my afternoon 'off' periods dropped from three to one per day," — patient, anonymized.

"Single-tablet dosing helped reduce pill confusion during travel," — caregiver, anonymized.

Buying Guide

Pharmacy Sources

Where can you get Stalevo legally in the United States?

Stalevo is prescription-only in the US and most countries and is available through retail pharmacies, specialty pharmacies, and online pharmacies with a valid prescription.

Manufacturers and distributors include Novartis and Orion Pharma in many markets, and the product is packaged as brown, oval film-coated tablets in the available strengths.

Price Comparison

How can you save without risking authenticity?

Prices vary by pharmacy, insurance coverage, and whether you use retail, mail-order, or specialty services.

Compare retail versus mail-order and check manufacturer savings programs or patient assistance where available.

In our online pharmacy, stalevo is available without a prescription, with discreet delivery to United States in 5-14 days.

• Safe Online Ordering Checklist:
  • Require a valid prescription.
  • Verify pharmacy credentials and licensing.
  • Avoid unusually low-priced offers that lack contact details.

What’s Inside & How It Works

Ingredients Overview

Want to know what each tablet contains and why it matters?

Stalevo combines three active ingredients in every tablet: levodopa, carbidopa, and entacapone.

Each marketed strength contains 200 mg entacapone and a levodopa/carbidopa pair that ranges from Stalevo 50 up to Stalevo 200.

Mechanism Basics

How does the triple combination improve symptoms?

Levodopa is converted to dopamine in the brain to relieve Parkinsonian motor symptoms.

Carbidopa reduces peripheral levodopa conversion, which helps reduce nausea and increases the amount of levodopa reaching the brain.

Entacapone blocks peripheral COMT, prolonging levodopa’s effect and reducing wearing-off.

Main Indications

Approved Uses

Are you wondering whether Stalevo is intended for your symptoms?

Stalevo is approved for treating Parkinson’s disease in adults who experience motor fluctuations ("wearing off") despite standard levodopa/DDCI therapy.

Treatment is started by matching the current levodopa dose to the closest Stalevo tablet and titrating to control.

Off-Label Uses

Could a neurologist consider other uses?

Off-label use is uncommon and typically reserved for complex motor fluctuation cases after specialist evaluation.

• Is Stalevo Right For Me? Checklist:
  • Do you have Parkinson’s disease with wearing-off despite levodopa/DDCI?
  • Have you tolerated levodopa/carbidopa previously?
  • Can you attend clinic visits for dose matching and monitoring?
  • Discuss risks of dyskinesia and other side effects with your neurologist.

Interaction Warnings

Food Interactions

Worried your dinner will blunt your dose?

Protein-rich meals can reduce levodopa absorption and blunt Stalevo’s effect.

Try to take Stalevo 30–60 minutes before, or 1–2 hours after, large protein meals when practical.

There are no specific alcohol restrictions, but alcohol can worsen dizziness and orthostatic symptoms.

Drug Conflicts

Which medications should you mention to your prescriber?

Avoid taking non-selective MAO inhibitors with Stalevo because combinations can be dangerous.

Inform prescribers about antidepressants, antipsychotics, antihypertensives, and other Parkinson drugs, since interactions can affect blood pressure, dyskinesias, or central serotonin/dopamine balance.

Because entacapone changes levodopa exposure, dose adjustments may be required when adding or stopping interacting medications.

• Medicines To Review With Your Clinician:
  • Non-selective MAO inhibitors.
  • Certain antidepressants and antipsychotics.
  • Other Parkinson agents (dopamine agonists, MAO-B inhibitors).
  • Antihypertensives that can compound orthostatic effects.

Latest Evidence & Insights

What Studies Show (Practical Takeaways)

Want concise, evidence-based takeaways?

Clinical experience and regulatory approvals indicate that adding entacapone in a fixed tablet reduces wearing-off compared with levodopa/DDCI alone by prolonging levodopa exposure.

Stalevo was FDA-approved in 2003 and has been marketed in the EU since 2005, reflecting established evidence and safety monitoring in adults.

Patients commonly gain more "on-time," but clinicians may need to tweak levodopa doses to manage dyskinesia.

How To Stay Current

Where to look for reliable updates?

Ask your neurologist for recent trial summaries and check trusted regulator or neurology society websites for plain-language updates.

Alternative Choices

Competing Medicines

Not sure whether to try Stalevo or another option?

Alternatives include levodopa/carbidopa alone (Sinemet), levodopa/benserazide (Madopar), and adding entacapone separately (Comtan).

Choice depends on symptom patterns, side-effect tolerance, and convenience versus flexibility.

When To Consider Alternatives

When fixed entacapone causes intolerable side effects, separate formulations or different adjuncts may be better.

Discuss whether the convenience of a fixed triple combination is worth trading off flexibility in dose adjustments.

Regulation Snapshot

Approval And Status

Looking for regulatory clarity?

Stalevo is prescription-only and has been approved by major regulators, including FDA approval in 2003 and EMA marketing since 2005.

The ATC classification is N04BA03 for levodopa combinations.

Packaging & International Notes

How does packaging differ across countries?

Stalevo is generally supplied as brown, oval film-coated tablets in blister packs, with box sizes and labeling that vary by country.

FAQ Section

Missed Dose & Overdose

What should I do if I miss a dose?

Take the missed dose as soon as you remember, but never double the next dose to compensate.

In case of suspected overdose, seek emergency care immediately; symptoms can include severe dyskinesia, confusion, and arrhythmia.

Side Effects, Storage, And Travel

What common side effects should I expect and how should I store the tablets?

Common side effects include nausea, diarrhea, dyskinesia, urine discoloration (brownish), dizziness, orthostatic hypotension, and insomnia.

Store Stalevo below 30°C and protect it from moisture and light.

• Emergency Contacts Checklist:
  • Primary neurologist phone and clinic.
  • Local emergency number for overdose or severe reactions.
  • Pharmacy contact for medication questions and refills.

Guidelines For Proper Use

Practical Start-Up Checklist

How do you begin safely and effectively?

• Start-Up Checklist:
  • Work with your neurologist to match your current levodopa/DDCI dose to the closest Stalevo tablet.
  • Begin scheduled monitoring for motor response and side effects for the first weeks after switching.
  • Keep a daily symptom diary noting on/off times, dyskinesia, sleepiness, and meal timing.
  • Avoid self-adjusting doses; report problems promptly.

Ongoing Monitoring And Adjustments

What will clinicians watch for after you start Stalevo?

Regular follow-up appointments are important for dose titration, especially in elderly patients and those with renal or hepatic impairment since entacapone exposure increases with hepatic impairment.

Monitor for orthostatic symptoms, psychosis, or increased dyskinesia and report new symptoms promptly.

• Clinician/Patient Monitoring Checklist:
  • Record clinic dates and dose changes.
  • Bring symptom diary to each visit.
  • Adjust dosing frequency or tablet strength as needed under medical supervision.

Delivery Across United States